Pharmacokinetics and pharmacodynamics of antiarrhythmic agents in patients with congestive heart failure
- 1 November 1987
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 114 (5) , 1280-1291
- https://doi.org/10.1016/0002-8703(87)90217-1
Abstract
No abstract availableThis publication has 65 references indexed in Scilit:
- Prevalence of arrhythmias detected by ambulatory electrocardiographic monitoring and of abnormal left ventricular ejection fraction in persons older than 62 years in a long-term health care facilityThe American Journal of Cardiology, 1987
- A consideration of antiarrhythmic therapy.Circulation, 1985
- Hemodynamic effects of intravenous flecainide relative to the level of ventricular function in patients with coronary artery diseaseAmerican Heart Journal, 1985
- Risk factors for sudden death after acute myocardial infarction: Two-year follow-upThe American Journal of Cardiology, 1984
- The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction.Circulation, 1984
- Antiarrhythmic Efficacy, Pharmacokinetics and Clinical Safety of Tocainide in Convalescent Myocardial Infarction PatientsChest, 1980
- Congestive Heart Failure Caused by Oral DisopyramideNew England Journal of Medicine, 1980
- The hemodynamic effects of intravenous tocainide in patients with heart disease.Circulation, 1978
- Adverse reactions to quinidine in hospitalized patients: Findings based on data from the boston collaborative drug surveillance programProgress in Cardiovascular Diseases, 1977
- Lidocaine Pharmacokinetics in Advanced Heart Failure, Liver Disease, and Renal Failure in HumansAnnals of Internal Medicine, 1973